| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |